Dabrafenib induced comparable responses in intracranial and extracranial metastases in patients with BRAF-mutant melanoma, according to study results.
MRV Research
Merck says new class of experimental cancer drug shows ‘promising’ results
Source: N.J.com November 2013 Merck’s cancer drug being evaluated in nine different malignancies kept more than four of five melanoma patients alive for a year in a study, including some…
Read More Adjuvant radiation therapy provided superior local control in desmoplastic melanoma
Data from two recent studies published in Cancer indicated adjuvant radiation therapy appeared to provide superior local control in patients with desmoplastic melanoma.
New research highlights urgent need to address distress in long-term melanoma survivors
More than one-third of Queensland melanoma survivors are suffering clinically significant psychological distress, despite the high survival rate associated with the cancer.